401 related articles for article (PubMed ID: 36085418)
21. Exosomal miR-27a-3p derived from tumor-associated macrophage suppresses propranolol sensitivity in infantile hemangioma.
Liu C; Zhao Z; Guo S; Zhang L; Fan X; Zheng J
Cell Immunol; 2021 Dec; 370():104442. PubMed ID: 34634611
[TBL] [Abstract][Full Text] [Related]
22. Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis.
Yang C; Dou R; Wei C; Liu K; Shi D; Zhang C; Liu Q; Wang S; Xiong B
Mol Ther; 2021 Jun; 29(6):2088-2107. PubMed ID: 33571679
[TBL] [Abstract][Full Text] [Related]
23. M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting TRIM62.
Zhang K; Li YJ; Peng LJ; Gao HF; Liu LM; Chen H
Biol Direct; 2023 Jan; 18(1):1. PubMed ID: 36631876
[TBL] [Abstract][Full Text] [Related]
24. Exosomal miR-200b-3p induce macrophage polarization by regulating transcriptional repressor ZEB1 in hepatocellular carcinoma.
Xu Y; Luan G; Liu F; Zhang Y; Li Z; Liu Z; Yang T
Hepatol Int; 2023 Aug; 17(4):889-903. PubMed ID: 36930410
[TBL] [Abstract][Full Text] [Related]
25. Bladder cancer cell‑secreted exosomal miR‑21 activates the PI3K/AKT pathway in macrophages to promote cancer progression.
Lin F; Yin HB; Li XY; Zhu GM; He WY; Gou X
Int J Oncol; 2020 Jan; 56(1):151-164. PubMed ID: 31814034
[TBL] [Abstract][Full Text] [Related]
26. Tumor-derived exosomal circFARSA mediates M2 macrophage polarization via the PTEN/PI3K/AKT pathway to promote non-small cell lung cancer metastasis.
Chen T; Liu Y; Li C; Xu C; Ding C; Chen J; Zhao J
Cancer Treat Res Commun; 2021; 28():100412. PubMed ID: 34119765
[TBL] [Abstract][Full Text] [Related]
27. Endometriosis derived exosomal miR-301a-3p mediates macrophage polarization via regulating PTEN-PI3K axis.
Huang Y; Zhu L; Li H; Ye J; Lin N; Chen M; Pan D; Chen Z
Biomed Pharmacother; 2022 Mar; 147():112680. PubMed ID: 35124383
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo evaluation of anti-tumoral effect of M1 phenotype induction in macrophages by miR-130 and miR-33 containing exosomes.
Moradi-Chaleshtori M; Bandehpour M; Soudi S; Mohammadi-Yeganeh S; Hashemi SM
Cancer Immunol Immunother; 2021 May; 70(5):1323-1339. PubMed ID: 33140190
[TBL] [Abstract][Full Text] [Related]
29. Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways.
Li W; Xin X; Li X; Geng J; Sun Y
Int Immunopharmacol; 2021 Dec; 101(Pt A):107585. PubMed ID: 34601333
[TBL] [Abstract][Full Text] [Related]
30. Exosome-depleted MiR-148a-3p derived from Hepatic Stellate Cells Promotes Tumor Progression via ITGA5/PI3K/Akt Axis in Hepatocellular Carcinoma.
Zhang X; Chen F; Huang P; Wang X; Zhou K; Zhou C; Yu L; Peng Y; Fan J; Zhou J; Lu Z; Hu J; Wang Z
Int J Biol Sci; 2022; 18(6):2249-2260. PubMed ID: 35414782
[TBL] [Abstract][Full Text] [Related]
31. Blocking exosomal miRNA-153-3p derived from bone marrow mesenchymal stem cells ameliorates hypoxia-induced myocardial and microvascular damage by targeting the ANGPT1-mediated VEGF/PI3k/Akt/eNOS pathway.
Ning W; Li S; Yang W; Yang B; Xin C; Ping X; Huang C; Gu Y; Guo L
Cell Signal; 2021 Jan; 77():109812. PubMed ID: 33164880
[TBL] [Abstract][Full Text] [Related]
32. Intervening in hnRNPA2B1-mediated exosomal transfer of tumor-suppressive miR-184-3p for tumor microenvironment regulation and cancer therapy.
Zhou X; Hong Y; Liu Y; Wang L; Liu X; Li Y; Yuan H; Hu F
J Nanobiotechnology; 2023 Nov; 21(1):422. PubMed ID: 37957722
[TBL] [Abstract][Full Text] [Related]
33. M2 Macrophage-Derived Exosomal miR-590-3p Attenuates DSS-Induced Mucosal Damage and Promotes Epithelial Repair via the LATS1/YAP/ β-Catenin Signalling Axis.
Deng F; Yan J; Lu J; Luo M; Xia P; Liu S; Wang X; Zhi F; Liu D
J Crohns Colitis; 2021 Apr; 15(4):665-677. PubMed ID: 33075119
[TBL] [Abstract][Full Text] [Related]
34. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.
Guo X; Qiu W; Liu Q; Qian M; Wang S; Zhang Z; Gao X; Chen Z; Xue H; Li G
Oncogene; 2018 Aug; 37(31):4239-4259. PubMed ID: 29713056
[TBL] [Abstract][Full Text] [Related]
35. Exosomal miR-6733-5p mediates cross-talk between glioblastoma stem cells and macrophages and promotes glioblastoma multiform progression synergistically.
Huang S; Liu L; Xu Z; Liu X; Wu A; Zhang X; Li Z; Li S; Li Y; Yuan J; Cheng S; Li H; Dong J
CNS Neurosci Ther; 2023 Dec; 29(12):3756-3773. PubMed ID: 37309294
[TBL] [Abstract][Full Text] [Related]
36. Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages.
Ying X; Wu Q; Wu X; Zhu Q; Wang X; Jiang L; Chen X; Wang X
Oncotarget; 2016 Jul; 7(28):43076-43087. PubMed ID: 27172798
[TBL] [Abstract][Full Text] [Related]
37. Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression.
Deng C; Huo M; Chu H; Zhuang X; Deng G; Li W; Wei H; Zeng L; He Y; Liu H; Li J; Zhang C; Chen H
Mol Cancer; 2024 Mar; 23(1):49. PubMed ID: 38459596
[TBL] [Abstract][Full Text] [Related]
38. Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia.
Guo Q; Fan Y; Wang Q; Li B; Qiu W; Qi Y; Pan Z; Zhang S; Zhao S; Yang K; Xu H; Li M; Gao Z; Xu J; Wang H; Wang S; Tang Q; Qiu J; Guo X; Deng L; Zhang P; Zhao R; Xue H; Wang C; Li G
Cell Death Dis; 2023 Feb; 14(2):147. PubMed ID: 36810326
[TBL] [Abstract][Full Text] [Related]
39. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages.
Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X
Cancer Lett; 2020 Apr; 474():36-52. PubMed ID: 31931030
[TBL] [Abstract][Full Text] [Related]
40. OxLDL-stimulated macrophage exosomes promote proatherogenic vascular smooth muscle cell viability and invasion via delivering miR-186-5p then inactivating SHIP2 mediated PI3K/AKT/mTOR pathway.
Ren L; Chen S; Yao D; Yan H
Mol Immunol; 2022 Jun; 146():27-37. PubMed ID: 35421738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
